IPM Take
Pregnancy is one of medicine’s clearest early-warning systems for cardiovascular risk. Preeclampsia, gestational hypertension, gestational diabetes and cardiac disorders during pregnancy can identify women who may later face hypertension, type 2 diabetes, heart failure, stroke or other cardiovascular complications. Yet most health systems still organise postpartum care as a short-term maternal-newborn transition, not as the beginning of lifelong cardiometabolic prevention. That is not a science gap. It is a care pathway failure.
Executive Summary
A Northside Hospital article published highlights a presentation by Dr Parham Eshtehardi at the American College of Cardiology’s annual scientific meeting in New Orleans. The presentation, “The Fourth Trimester: Long-Term CV Risk Reduction After Pregnancy in Patients with Cardiac Disorders,” argued that pregnancy complications and cardiac disorders should trigger extended cardiovascular surveillance and prevention beyond the traditional postpartum window.
The message aligns with a growing policy shift. In 2026, the American College of Cardiology published an Expert Consensus Decision Pathway on postpartum cardiovascular care, recommending structured care that begins immediately after delivery and continues through the first year. In Europe, the 2025 ESC Guidelines on cardiovascular disease and pregnancy added new guidance on Pregnancy Heart Teams and the long-term effects of adverse pregnancy outcomes. WHO’s postnatal care recommendations emphasise continuity after birth, while national systems such as the UK, Australia and the US are moving unevenly toward stronger postpartum follow-up.
The evidence base is clear. The American Heart Association has recognised adverse pregnancy outcomes, including hypertensive disorders of pregnancy, preterm delivery and gestational diabetes, as markers of increased long-term cardiovascular risk. CDC data show that more than 80% of pregnancy-related deaths in the United States are considered preventable, and that many occur after delivery.
The policy conclusion is blunt: pregnancy history should become a routine cardiovascular risk variable. Postpartum care should not end at six weeks. It should connect obstetrics, cardiology, primary care, diabetes prevention, blood pressure monitoring, mental health, contraception, breastfeeding support and long-term risk reduction.
Why it matters
- Policymakers and public authorities: Maternal health strategies must move beyond survival at delivery. Postpartum cardiovascular surveillance, insurance coverage, primary care transition and remote monitoring should be treated as prevention infrastructure.
- Clinicians and providers: Pregnancy history should be part of routine cardiovascular assessment. Preeclampsia, gestational hypertension, gestational diabetes, preterm birth and pregnancy-related cardiac disease should trigger follow-up, not disappear into old obstetric notes.
- Payers and HTA bodies: Coverage of postpartum blood pressure monitoring, telehealth, cardiology referral, diabetes screening and preventive care could reduce downstream costs from heart failure, stroke, chronic hypertension and type 2 diabetes.
- Patients and advocates: Women should not be told that pregnancy complications are “over” once the baby is delivered. They need clear information about future cardiovascular risk and access to long-term support.
- Digital health and AI leaders: Telemonitoring and risk algorithms could help, but only if they are integrated into care pathways and tested for equity across race, income, geography, language and digital access.
Pregnancy is often described as a cardiovascular stress test. Health systems still behave as if the test ends at delivery.
That is the dangerous gap highlighted by a Northside Hospital cardiology article published after ACC.26. During a presentation in New Orleans, Dr Parham Eshtehardi argued that a successful delivery is not the endpoint for patients with cardiac disorders. It should be the trigger for surveillance, risk-factor control and prevention.
That sentence should be written into maternal health policy.
For too long, postpartum care has been treated as a short transition back to “normal.” A six-week visit. A blood pressure check if someone remembers. A handoff to primary care that may or may not happen. A cardiology referral only if symptoms become impossible to ignore.
But pregnancy complications are not isolated events. They are warning signals.
Hypertensive disorders of pregnancy, including preeclampsia and gestational hypertension, are linked to later chronic hypertension and cardiovascular disease. Gestational diabetes is linked to later type 2 diabetes and cardiometabolic risk. Preterm delivery, placental complications and pregnancy-related cardiac disorders can all reveal future vulnerability.
The American Heart Association has been explicit: adverse pregnancy outcomes are associated with long-term risk of cardiovascular disease. The implication is simple but still under-implemented: pregnancy history belongs in cardiovascular risk assessment.
The policy failure is that most systems do not treat it that way.
A woman can have preeclampsia in her 30s, develop hypertension in her 40s, present with heart failure or stroke later, and still have the original pregnancy complication treated as a past obstetric event rather than a cardiovascular risk marker. That is not personalised medicine. It is institutional amnesia.
The United States is beginning to respond. In May 2026, the American College of Cardiology published an Expert Consensus Decision Pathway on postpartum cardiovascular care for patients with, or at risk for, premature and long-term cardiovascular disease. The pathway recommends structured postpartum cardiovascular care beginning immediately after delivery and continuing through the first year, including early follow-up for symptom monitoring, blood pressure management, cardiovascular risk-factor modification and transition to longitudinal preventive care.
That is a major shift. It recognises that the postpartum year is not administrative dead space. It is a prevention window.
The US has also moved on coverage. As of March 2026, 48 states and Washington, DC had extended Medicaid postpartum coverage to 12 months, under a policy option made permanent by the Consolidated Appropriations Act of 2023. That matters because insurance loss after pregnancy is a quiet driver of missed care. A risk factor cannot be managed if the patient falls out of coverage two months after delivery.
But coverage alone does not create care.
The US still has deep racial and socioeconomic disparities in maternal mortality and cardiovascular outcomes. CDC data have shown that more than 80% of pregnancy-related deaths are preventable. More than half occur after delivery, and cardiovascular conditions remain a major contributor. The postpartum risk window is not theoretical. It is where women are already dying.
Europe is moving through a different route. The 2025 European Society of Cardiology Guidelines on cardiovascular disease and pregnancy added updated risk scoring, new content on Pregnancy Heart Teams and a dedicated chapter on the long-term effects of adverse pregnancy outcomes. That matters because it shifts pregnancy-related cardiovascular risk from individual clinician awareness into guideline architecture.
The Pregnancy Heart Team model is especially important. Cardio-obstetrics cannot be a heroic side project run by a few motivated clinicians. It needs organised multidisciplinary care: obstetrics, cardiology, anaesthesia, maternal-fetal medicine, primary care, nursing, midwifery and, when needed, endocrinology and nephrology.
The United Kingdom has strong guidance on hypertension in pregnancy through NICE, including follow-up and postnatal review for women whose pregnancies were complicated by hypertension. But the UK faces the same implementation question as everyone else: is postpartum cardiovascular risk actively tracked after the obstetric episode ends, or does responsibility drift between maternity care, general practice and specialist services?
Australia shows another version of the gap. The Heart Foundation recognises the need for pregnancy care and long-term cardiovascular risk management, and Australian research has found that many women with a history of hypertensive disorders of pregnancy are unaware of their increased cardiovascular risk and are not receiving recommended preventive care. Awareness is not a soft endpoint. It is the first step in patient navigation.
Globally, WHO’s postnatal care recommendations emphasise continuity and a positive postnatal experience, with multiple postnatal contacts in the first six weeks. That is necessary. But for cardiovascular prevention, six weeks is not enough. The most serious cardiometabolic consequences unfold over months, years and decades.
This is the global policy challenge: maternal health systems are designed around pregnancy and birth; cardiovascular prevention systems are designed around midlife risk. The women at the intersection are too often seen by neither system at the right time.
The solution is not complicated in principle.
First, pregnancy history should become a standard field in cardiovascular records. Clinicians should routinely ask about preeclampsia, gestational hypertension, gestational diabetes, preterm birth, fetal growth restriction and cardiac symptoms or diagnoses during pregnancy.
Second, high-risk postpartum patients should leave maternity care with a cardiovascular follow-up plan, not vague advice. That plan should include blood pressure monitoring, diabetes screening, lipid and kidney risk assessment where appropriate, symptom education, medication review, contraception and breastfeeding-compatible treatment planning.
Third, postpartum blood pressure monitoring should be normalised and reimbursed. Remote monitoring is one of the most practical tools in this space. It can detect hypertension early, reduce unnecessary visits, and help clinicians act before symptoms escalate. But telemonitoring only works if someone is paid to review the data and respond.
Fourth, cardio-obstetrics should be built into health systems, not left as a boutique service. Every region does not need a tertiary Pregnancy Heart Team in every hospital, but every system needs referral criteria, escalation pathways and clear responsibility for long-term follow-up.
Fifth, equity has to be designed into the model. The patients most likely to miss postpartum care are often the patients at highest risk: women with low income, unstable insurance, transport barriers, language barriers, rural residence, racism in care settings, mental health burden or caregiving constraints. A clinic-based model that assumes time, transport and trust will reproduce the same gaps it claims to fix.
Sixth, the policy conversation needs to connect maternal health and cardiometabolic health. Gestational diabetes should trigger diabetes prevention. Preeclampsia should trigger blood pressure surveillance. Pregnancy-related heart failure should trigger long-term cardiology follow-up. Obesity, kidney disease and hypertension should not be managed as isolated problems after birth.
This is where personalised medicine can become practical.
Pregnancy offers a natural risk stratification moment. It reveals who is vulnerable earlier than standard cardiovascular risk calculators often do. A woman with an adverse pregnancy outcome may not look high-risk on a conventional 10-year cardiovascular score, especially if she is young. But her pregnancy history may tell a different story.
Ignoring that history is bad prevention.
The fourth trimester should not be a soft slogan. It should be a policy demand.
It means extending care beyond delivery. It means funding surveillance. It means connecting obstetrics to cardiology and primary care. It means protecting coverage. It means giving women their risk information clearly and early. It means treating pregnancy complications as cardiovascular signals, not temporary obstetric drama.
The politics are uncomfortable because they expose how little health systems invest in women after birth. The baby is delivered. The crisis appears over. The woman is expected to disappear back into work, family, caregiving and fragmented care.
But the heart does not reset at discharge.
Pregnancy may be the stress test. Postpartum care is where the health system either acts on the result, or throws it away.
